ABSTRACT. In the genome of strains of very virulent Marek's disease virus serotype 1(vvMDV1), such as Md5 and RB1B, the meq open reading frame (ORF) encoding a 339-amino-acid bZIP protein, is present, while a slightly longer meq ORF, termed as L-meq, in which a 180-bp sequence is inserted into the meq ORF is found in other strains of MDV1, such as CVI988/R6 and attenuated JM. When chickens were infected with vvMDV1 strains and the meq gene was amplified by nested polymerase chain reaction (PCR), the meq gene was detected throughout the experimental period for 7 weeks post inoculation (pi). However, the L-meq gene was also detected at 3 to 5 weeks and 3 to 4 weeks pi. in Md5-infected and RB1B-infected chickens, respectively. In the case of chickens infected with an attenuated MDV1, the JM strain, the L-meq gene was detected at 2 to 7 weeks pi., and the meq gene was also detected at 2 to 6 weeks pi. Both L-meq and meq genes were detected in chickens infected with an attenuated nononcogenic vaccine strain of MDV1 (CVI988/R6), throughout the experimental period. Though quantitative PCR was not performed, a larger amount of the PCR products corresponding to the L-meq than the meq gene was amplified from chickens infected with JM or CVI988/R6. These results suggest that a dynamic population shift between the MDV subpopulations displaying meq and L-meq genes occurs in chickens during the course of MDV infection. Since the MDV subpopulation that displays the L-meq gene only displays it during the latent phase, the L-meq and its gene product, if any, might contribute to the maintenance of the MDV latency.
Marek's disease virus (MDV), classified as an avian alphaherpesviruses, is an oncogenic herpesvirus of chickens and can cause a contagious, lymphoproliferative diseases in them [5] . The pathogenesis of MD can be sequentially divided into three phases: early cytolytic infection; latent infection; and secondary cytolytic infection with immunosuppression and tumor development [6, 18, 26] . The activation of T cells during the cytolytic infection is important for the establishment of the latency which starts at 1-2 weeks after the infection, since the latent infection of MDV is maintained in activated T cells [3, 4] . MDV causes secondary immnosuppression [2] , and lymphomas develop in several visceral organs, nerves, muscles and skins in chickens as early as 3 weeks after infection [26] .
MDV strains are classified into three serotypes based on their pathogenecity. Only serotypes 1 strains of MDV are oncogenic though the transformation mechanism by MDV1 has not been fully understood [1, 22] . An MDV1-specific gene, meq, has been identified, and its gene product, Meq, a basic leucine zipper (bZIP) oncoprotein, has been detected in all tumor samples and established MDV-transformed Tcell lines examined thus far, suggesting that Meq protein plays an important role in the transformation by MDV [19, 20, 22, 23] . The Meq protein resembles the Fos/Jun family of oncoprotein in that it has a basic leucine zipper motif near its N terminus and an upstream domain rich in basic amino acids [8, 13, 14, 21] . In addition, the Meq protein contains a C-terminal 33-amino acid proline-rich region which is a potent transcriptional transactivator. However, the role of the Meq protein in MDV transformation remains to be determined (Fig. 1) .
We have previously identified a difference in the meq gene between oncogenic and nononcogenic strains of MDV1: a 178-bp insertion was found in the meq open reading frames (ORF) of CVI988 and CVI988/R6, an attenuated vaccine strain of MDV1 [9, 10] . This meq gene, termed Lmeq, could potentially encode a Meq protein with a different transactivation domain, though the function of the L-meq gene and its gene product remains unknown. By southern blot analysis, the L-meq gene was not detected in Md5 and RB1B, strains of vvMDV1, suggesting that L-meq is associated with the loss of oncogenicity and pathogenicity of MDV1. However, a small amount of the meq gene in addition to L-meq gene was also detected in an attenuated vaccine strain of MDV1, CVI988, suggesting MDV1 strains (even cloned) contains at least two subpopulations, ones with the meq gene and the other with the L-meq gene [9] . Thus, in order to obtain insight into the function of the Lmeq gene, changes in the meq gene in relation to stage of infection was monitored in chickens infected with different strains of MDV1. In addition, to determine whether the meq gene is converted to the L-meq gene at the viral genome during the serial passages in vitro, oncogenic MDV1 was passaged in vitro 35 or 78 times, and changes in the meq gene structure was analyzed. [25] , and virulent MDV1, JM [7] , were obtained from chicken kidney cell culture from experimentally infected chickens. The JM strain used in this study was found to be attenuated as determined by PCR analysis of the 132-bp direct repeat in the BamHI-H region of the MDV genome [16] . A vaccine strain of MDV1, CVI988/R6, was purchased from Gehn Corp. Inc. (Gifu, Japan). All viral strains were propagated in chicken embryo fibroblasts (CEF). When cytopathic effects were confluent, the infected cells were harvested and, virus titers were measured by plaque assay. These infected CEF was used for the viral inoculation of chickens.
MATERIALS AND METHODS

Chickens
Inoculation of viruses and sample collection from infected chickens: Groups of 3-day-old chickens (35 chickens/ group) were inoculated intraperitoneally with either 10,000 or 2,000 plaque forming unit (PFU)/0.2 ml of Md5, 2,000 PFU/0.2 ml of RB1B, 10,000 PFU/0.2 ml of attenuated JM, or 10,000 or 2,000 PFU/0.2 ml of CVI988/R6. We used commercial, B19 and B21 chickens for the inoculation of Md5, and used commercial and B19 chickens for the inoculation of RB1B, JM, and CVI988/R6.
Spleen and blood were collected from 5 chickens from each group infected with MDV at every week for 7 weeks after inoculation. Peripheral blood mononuclear cells (PBMC) and spleen cells were prepared by centrifugation over the Ficoll-Conray gradient to remove dead cells and red blood cells from blood and spleen minced by frostended slide glasses, separately, and used for the extraction of total cellular DNA.
Extraction of DNA from PBMC and spleen cells: Total cellular DNA was extracted from PBMC and spleen cells by using SepaGene (Sankoujunyaku Co., Japan). The DNA was treated with RNase and re-extracted with phenol-chloroform-isoamyl alcohol (25:24:1), precipitated with ethanol, and dissolved in distilled water.
Nested polymerase chain reaction (PCR): Total cellular DNA samples extracted from PBMC and spleen cells of infected chickens were used as a template for nested PCR amplification to detect the meq gene. The meq-specific primers used in this study were shown in Table 1 . The first round of PCR was performed with a primer set, M-S and M-AS, to amplify the 1.0-kb meq or 1.2-kb L-meq gene fragments as described by Lee et al. [9, 10] . After the amplification, l µl of the reaction was used for the second round of PCR. The second round of PCR was performed in the 20 µl reaction mixture containing 1.5 mM MgCl 2 , and a primer set, 10 pM of MR-S and MR-AS, to amplify a 0.5-kb meq or 0.7-kb L-meq fragment. Amplification was carried out over 35 cycles of 94°C for 45 sec, 55°C for 45 sec, and 72°C for 1.5 min. The amplified fragments were separated on an agarose gel (1.5%) and visualized by staining with ethidium bromide.
Serial passages in vitro of Md5 and JM:
In order to detect the change in the meq gene structure in vitro, Md5 and attenuated JM strains were serially passaged for 78 times in CEF, and RB1B and CVI988/R6 strains were serially passaged for 35 times in CEF. Then, total cellular DNA was extracted from infected CEF as described above and analyzed by PCR using pairs of meq-, 132-bp direct repeat-, and pp38-specific primers [9, 11] , and Southern blot analysis as described below. It has been reported that the copy number of the 132-bp direct repeat is expanded during the attenuation [16] .
Southern blot hybridization: Total cellular DNA samples (10 µg or 20 µg) extracted from infected CEF and from PBMC and spleen cells of chickens infected with Md5, JM or CVI988/R6 were digested with PstI and BamHI at 37°C for overnight. The digested DNA was fractionated on a 1.2% agarose gel, and transferred onto a membrane filter, Hybond-N (Amersham Pharmacia Biotech). The meq-specific probe was prepared by using the AlkPhos Direct labeling system (Amersham-Pharmacia Biotech) as described by Lee et al. [9, 10] . The membrane was prehybridized, and hybridized with the meq-specific probe by using CDP-star detection reagents (Amersham-Pharmacia Biotech) according to the instruction provided by the manufacturer.
RESULTS
Changes in the meq gene during attenuation in vitro:
When PCR analysis was done with DNA samples prepared from MDV1 strains serially passaged in vitro, a 479-bp fragment containing 2 copies of the 132-bp direct repeat was amplified from Md5 (passage 35) and RB1B (passage 35), while multiple bands including over 3 copies of the 132-bp repeat were shown from Md5 (passage 78), JM (passage 35 and 78) and CVI988/R6 (passage 35) ( Fig. 2A) . On the other hand, no difference was found in the meq and pp38 genes between low-passaged and high-passaged MDV1, Md5 and RB1B. These results were also confirmed by southern blot analysis (Fig. 2B) . Thus, no genomic change occurred in the meq gene during serial passage in vitro, at least by the number of passages performed in this study.
Detection of the meq gene in chickens infected with vvMDV1:
When the meq gene was monitored in chickens infected with Md5, the meq gene was detected in most of infected chickens at 1 to 7 weeks post inoculation (pi) (Fig.  3A, Table 2 ). Interestingly, the L-meq gene was also detected in Md5-infected chickens at 3 to 5 weeks pi, presumably the latent phase of the MDV infection. At that time, the intensities of the amplified products were higher in the L-meq than meq gene by nested PCR. Similar results were obtained in the case of chickens infected with RB1B, another vvMDV1 strain (Fig. 3B, Table 2 ). The meq gene was detected in infected chickens at 1 to 7 weeks pi, and the L-meq gene was detected at 3 to 4 weeks pi. The meq gene was continuously detected in chickens infected with vvMDV1 as far as 9 weeks pi (data not shown). These changes were observed in commercial, B19 and B21 chickens.
Detection of the meq gene in chickens infected with JM or CVI988/R6: When the meq gene was monitored in chicken infected with attenuated JM in which the L-meq gene was already identified, the L-meq gene was detected in most of the infected chickens at 2 to 7 weeks pi (Fig. 4A, Table 2 ). In addition, the meq gene was detected at 2 to 6 weeks pi. In the case of chickens infected with CVI988/R6 (10,000 PFU/ chicken), both the meq and L-meq genes were detected at 2 to 7 weeks pi (Fig. 4B, Table 2 ). However, both the meq and L-meq genes were under the detectable level in chickens infected with 2,000 PFU of CVI988/R6 (data not shown). The intensities of the amplified products detected by nested PCR were higher in the L-meq than meq gene during the experimental period. These changes were observed in commercial, B19 and B21 chickens.
DISCUSSION
There is evidence that the meq gene and its gene product, Meq, play important roles in transformation of CD4+ T cells by MDV1. The Meq protein is a transactivating bZIP protein homologous to fos and jun oncogene products, and has an anti-apoptotic activity [12, 14, 15] . The Meq protein is consistently expressed in the vast majority of MD-transformed cell lines and CD4+ T cells obtained from lymphomas [24] . Oligonucleotides and RNA complementary to the meq gene can prevent the growth of MDV cell lines [29] , and overexpression of Meq in rat-2 fibroblasts by recombinant murine retrovirus leads to transformation of the cells [12, 15] . Furthermore, MDV1 mutants lacking a functional meq gene failed to cause tumors in chickens [23] . However, as the replication of the virus in the chicken was hampered, it is not certain whether the oncogenicity of the mutant resulted from a loss of transforming capacity, poor growth of the virus, or elimination of the infection by the immune system.
By the comparison of the genome of oncogenic and attenuated MDV1, several changes in the viral genome have been identified including the expansion of the 132-bp direct repeats located in the internal repeat region flanking the long unique region (IRL) [16, 27] . In addition, recently, differences in the meq gene between oncogenic and nononcogenic MDV1 have been reported [9] : the L-meq gene was found in nononcogenic but not oncogenic MDV1. However, the function and biological significance of the L-meq gene has not been elucidated though this difference could explain why an attenuated MDV1 strain (CVI988) is nononcogenic.
In this study, by the nested PCR method, we monitored the meq gene in chickens infected with strains of oncogenic and nononcogenic MDV1 for 7 weeks pi. Surprisingly, both the meq and L-meq genes were detected in infected chickens though the time at which these genes were detected were different. These results raise a possibility that strains of MDV1 comprises at least 2 subpopulations, one with the meq gene and the other with the L-meq gene, although the presence of the third subpopulation which has both meq and L-meq genes in internal and terminal repeat regions respectively can not be ruled out [9] . During the infection, a dynamic shift from one subpopulation of MDV1 to the other may occur due to some selective pressures from host chickens. Another possibility is that the meq gene is actively converted to the L-meq gene by unknown mechanisms during the infection. However, the latter case is unlikely since both the meq and L-meq genes were detected as early as 2 weeks pi, and since no change in the meq gene was observed in MDV1 strains serially passaged in vitro.
It is of interest that the L-meq gene was detected at 3 to 5 weeks pi which corresponds to the latent phase in chickens infected with vvMDV1, Md5 and RB1B. This observation suggests that the L-meq gene and its gene product, if any, may contribute to the maintenance of the latent infection of MDV1while the Meq protein play a key role in transformation of CD4+ T cells (Table 3 ). In fact, only the meq gene was detected in chickens infected with oncogenic MDV1, Md5 and RB1B, after 6 weeks pi, while a greater amount of the L-meq than meq gene was detected in chickens infected with less oncogenic and nononcogenic MDV1, JM and CVI988/R6, throughout the experimental period. In addition, only the meq gene is detected in liver and spleen tumors caused by MDV (Ohashi et al., prepared for publication). These results also suggest that the presence of both the meq and L-meq genes during the latent phase and the subsequent population shift seen in MDV1 with the meq gene might be a prerequisite for the transformation of target cells by MDV1. MDV1 could potentially express not only the meq but also L-meq gene in infected chickens depending on the stage of MDV1 infection. In the future, it will be necessary to characterize the meq gene in T cell subsets, especially CD4 + T cells, which are targets for transformation by MDV1 in order to know the biological significance of the L-meq gene and its coding protein. Furthermore, studies on the function of the L-meq gene at the viral transcription are now in progress.
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